Premier Alternatives

VeraDermics (NYS: MANE)

Drug Discovery · New Haven, CT · Founded 2019 · Publicly Held

Veradermics Inc clinical-stage biopharmaceutical company focused on developing therapeutics to address pervasive treatment challenges in prevalent aesthetic and dermatological conditions. VeraDermics (NYS: MANE) is based in New Haven, CT and was founded in 2019. It is now publicly traded; this page covers its private-market history, where its last recorded valuation was $596 million (Feb 2026). It has raised $519 million across 1 recorded round; the latest was a $150 million Series C in Oct 2025.

Last price · $/share
—
Implied valuation
$596.3M
Total raised
$518.6M
Last round
Later Stage VC (Series C)
Oct 2025
How much has VeraDermics (NYS: MANE) raised?
$518.6Macross 1 recorded rounds · Oct 2025 – Oct 2025

Most recently, VeraDermics (NYS: MANE) raised $150.0M in its Later Stage VC (Series C) (Oct 2025).

Free account
More of VeraDermics (NYS: MANE) with a free account
  • ·The complete investor list: 26 names
  • ·Watch VeraDermics (NYS: MANE): the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

VeraDermics (NYS: MANE) round by round

1 rounds
Oct 2025Later Stage VC (Series C)$150.0M▮
+ 1 more investors · free account

How much has VeraDermics (NYS: MANE) raised?

VeraDermics (NYS: MANE) has raised $519 million in total; 1 of its rounds is on record. The largest on record was a $150 million Series C in Oct 2025.

VeraDermics (NYS: MANE) investors

26 investors are on record for VeraDermics (NYS: MANE), including Viking Global Investors, Connecticut Innovations, The Invus Group and Osage University Partners. By type, the record holds 3 venture capital firms, 3 hedge funds and 2 asset managers. The Series C in Oct 2025 drew 10 investors.

For fundraisers
Raising for a company like VeraDermics (NYS: MANE)?

26 investors have backed VeraDermics (NYS: MANE) — start your target list with the firms already writing checks in drug discovery.

See all 26 investors →

Frequently asked about VeraDermics (NYS: MANE)

How much has VeraDermics (NYS: MANE) raised?
VeraDermics (NYS: MANE) has raised $518.6M in total across 1 recorded funding rounds.
When was VeraDermics (NYS: MANE)'s last funding round?
VeraDermics (NYS: MANE)'s most recent recorded round was Later Stage VC (Series C) in Oct 2025, raising $150.0M.